Improving the Therapeutic Ratio for Stereotactic Treatment of Prostate Cancer
November 15, 2023
Andrew Loblaw BSc MD MSc FRCPC CIP FASCO
Radiation Oncologist, Clinician Scientist, and dual Professor in the Department of Radiation Oncology and the Institute of Health Policy Management & Evaluation at the University of Toronto. He’s the Site Group Co-Lead for Genitourinary Oncology at Sunnybrook.
To review outcomes have changed for men treated with radiotherapy over last 20 years
To discuss strategies to improve therapeutic ratio
To think about what the future of prostate care might look like